Cloned (Comment) | Organism |
---|---|
gene Vkor, sequence comparisons | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
C43A | naturally occuring mutant, active in presence of DTT, which helps to bypass C43 | Homo sapiens |
C51A | naturally occuring mutant, active in presence of DTT, which helps to bypass C43 | Homo sapiens |
I123N | naturally occuring mutant | Homo sapiens |
R58G | naturally occuring mutant | Homo sapiens |
W59R/W59C/W59L | naturally occuring mutant | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
warfarin | hVKOR is directly and irreversibly inhibited by warfarin, hVKOR is the target of a common anticoagulant, warfarin. Tyr139 in hVKOR is part of the warfarin binding site | Homo sapiens | |
warfarin | - |
Mycobacterium tuberculosis |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
endoplasmic reticulum membrane | integral membrane protein, topology, overview | Homo sapiens | 5789 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
2-methyl-3-phytyl-1,4-naphthoquinone + oxidized dithiothreitol + H2O | Homo sapiens | - |
2,3-epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone + 1,4-dithiothreitol | - |
? | |
2-methyl-3-phytyl-1,4-naphthoquinone + oxidized dithiothreitol + H2O | Mycobacterium tuberculosis | - |
2,3-epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone + 1,4-dithiothreitol | - |
? | |
additional information | Homo sapiens | the enzyme, driven by the reducing agent DTT, reduces both vitamin K 2,3-epoxide and vitamin K to the activated hydroquinone form | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Mycobacterium tuberculosis | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | high expression level | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
2-methyl-3-phytyl-1,4-naphthoquinone + oxidized dithiothreitol + H2O | - |
Homo sapiens | 2,3-epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone + 1,4-dithiothreitol | - |
? | |
2-methyl-3-phytyl-1,4-naphthoquinone + oxidized dithiothreitol + H2O | - |
Mycobacterium tuberculosis | 2,3-epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone + 1,4-dithiothreitol | - |
? | |
additional information | the enzyme, driven by the reducing agent DTT, reduces both vitamin K 2,3-epoxide and vitamin K to the activated hydroquinone form | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
vitamin K epoxide reductase | - |
Homo sapiens |
vitamin K epoxide reductase | - |
Mycobacterium tuberculosis |
VKOR | - |
Homo sapiens |
VKOR | - |
Mycobacterium tuberculosis |
VKOR complex | - |
Homo sapiens |
VKOR complex | - |
Mycobacterium tuberculosis |
VKORC1 | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
evolution | the enzyme belongs to the thiol-disulfide oxidoreductases. VKORL1, EC 1.1.4.2, is more highly conserved among vertebrates than its evolutionary relative VKOR, EC 1.1.4.1. The human paralogous proteins are 42% identical with 60% similarity | Homo sapiens |
malfunction | warfarin interfers with the vitamin K cycle by inhibiting VKOR thus limiting the available activated hydroquinone cofactor and functionally impeding various blood clotting proteins that are dependent on gamma-carboxyglutamate residues | Homo sapiens |
metabolism | vitamin K cycle, overview | Homo sapiens |
additional information | structure-function relationship, the CXXC redox center active site (hVKOR Cys132 and Cys135) is located in the final transmembrane helix near the endoplasmic reticulum lumen/periplasmic side of the membrane, overview | Homo sapiens |
physiological function | vitamin K dependent oxidative protection is independent of VKOR inhibition by warfarin and GGCX inhibition by 2-chloro-vitamin K1, which indicated that vitamin K plays potential physiological roles outside of the realm of carboxylation. The hVKORL1, EC 11.4.2, turnover rate for vitamin K 2,3-epoxide reductase activity is significantly slower than for hVKOR | Homo sapiens |